Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | SLC2A4RG (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SLC2A4RG mRNA | CTD | PMID:28628672 | all-trans-retinoic acid | increases expression | ISO | SLC2A4RG (Homo sapiens) | 6480464 | Tretinoin results in increased expression of SLC2A4RG mRNA | CTD | PMID:23724009 | all-trans-retinoic acid | decreases expression | ISO | SLC2A4RG (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of SLC2A4RG mRNA | CTD | PMID:33167477 | antirheumatic drug | increases expression | ISO | SLC2A4RG (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of SLC2A4RG mRNA | CTD | PMID:24449571 | benzo[a]pyrene | increases methylation | ISO | SLC2A4RG (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of SLC2A4RG promoter | CTD | PMID:27901495 | benzo[a]pyrene | decreases expression | ISO | SLC2A4RG (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of SLC2A4RG mRNA | CTD | PMID:20106945 and PMID:26238291 | bisphenol A | affects expression | ISO | SLC2A4RG (Homo sapiens) | 6480464 | bisphenol A affects the expression of SLC2A4RG mRNA | CTD | PMID:30903817 | bisphenol F | multiple interactions | ISO | SLC2A4RG (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SLC2A4RG mRNA | CTD | PMID:28628672 | cobalt dichloride | decreases expression | ISO | SLC2A4RG (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of SLC2A4RG mRNA | CTD | PMID:19376846 | copper atom | multiple interactions | ISO | SLC2A4RG (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of SLC2A4RG mRNA | CTD | PMID:20971185 | copper(0) | multiple interactions | ISO | SLC2A4RG (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of SLC2A4RG mRNA | CTD | PMID:20971185 | copper(II) sulfate | decreases expression | ISO | SLC2A4RG (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of SLC2A4RG mRNA | CTD | PMID:19549813 | coumestrol | increases expression | ISO | SLC2A4RG (Homo sapiens) | 6480464 | Coumestrol results in increased expression of SLC2A4RG mRNA | CTD | PMID:19167446 | coumestrol | multiple interactions | ISO | SLC2A4RG (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC2A4RG mRNA | CTD | PMID:19167446 | cyclosporin A | decreases expression | ISO | SLC2A4RG (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of SLC2A4RG mRNA | CTD | PMID:20106945 and PMID:25562108 | dexamethasone | multiple interactions | ISO | SLC2A4RG (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SLC2A4RG mRNA | CTD | PMID:28628672 | diazinon | increases methylation | ISO | SLC2A4RG (Homo sapiens) | 6480464 | Diazinon results in increased methylation of SLC2A4RG gene | CTD | PMID:22964155 | doxorubicin | decreases expression | ISO | SLC2A4RG (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of SLC2A4RG mRNA | CTD | PMID:29803840 | Enterolactone | multiple interactions | ISO | SLC2A4RG (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC2A4RG mRNA | CTD | PMID:19167446 | geraniol | decreases expression | ISO | SLC2A4RG (Homo sapiens) | 6480464 | geraniol results in decreased expression of SLC2A4RG mRNA | CTD | PMID:27683099 | hydrogen peroxide | affects expression | ISO | SLC2A4RG (Homo sapiens) | 6480464 | Hydrogen Peroxide affects the expression of SLC2A4RG mRNA | CTD | PMID:20044591 | indometacin | multiple interactions | ISO | SLC2A4RG (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SLC2A4RG mRNA | CTD | PMID:28628672 | lead(0) | increases expression | ISO | SLC2A4RG (Homo sapiens) | 6480464 | Lead results in increased expression of SLC2A4RG mRNA | CTD | PMID:19921347 | menadione | affects expression | ISO | SLC2A4RG (Homo sapiens) | 6480464 | Vitamin K 3 affects the expression of SLC2A4RG mRNA | CTD | PMID:20044591 | ozone | multiple interactions | ISO | SLC2A4RG (Homo sapiens) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of SLC2A4RG mRNA | CTD | PMID:35430440 | rotenone | increases expression | ISO | SLC2A4RG (Homo sapiens) | 6480464 | Rotenone results in increased expression of SLC2A4RG mRNA | CTD | PMID:29955902 | sunitinib | decreases expression | ISO | SLC2A4RG (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of SLC2A4RG mRNA | CTD | PMID:31533062 | tamibarotene | increases expression | ISO | SLC2A4RG (Homo sapiens) | 6480464 | tamibarotene results in increased expression of SLC2A4RG mRNA | CTD | PMID:17229644 | troglitazone | decreases expression | ISO | SLC2A4RG (Homo sapiens) | 6480464 | Troglitazone results in decreased expression of SLC2A4RG mRNA | CTD | PMID:19140230 | valproic acid | decreases expression | ISO | SLC2A4RG (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of SLC2A4RG mRNA | CTD | PMID:29154799 | valproic acid | increases expression | ISO | SLC2A4RG (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of SLC2A4RG mRNA | CTD | PMID:23179753 | |